高级检索
当前位置: 首页 > 详情页

The DNA damage-independent ATM signalling maintains CBP/DOT1L axis in MLL rearranged acute myeloid leukaemia

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Tongji Univ, Tongji Hosp, Sch Med, Dept Hematol, Shanghai 200065, Peoples R China [2]Tongji Univ, East Hosp, Sch Med, Shanghai 200120, Peoples R China [3]Tongji Univ, Tongji Hosp, Sch Med, Postdoctoral Stn Clin Med, Shanghai 200092, Peoples R China [4]Fudan Univ, Eye & ENT Hosp, Shanghai 200031, Peoples R China [5]Tongji Univ, Tongji Hosp, Sch Med, Dept Pathol, Shanghai 200065, Peoples R China [6]Shanghai Jiao Tong Univ, Hongqiao Int Inst Med, Shanghai Tongren Hosp, Key Lab Cell Differentiat & Apoptosis,Chinese Mini, Shanghai 200025, Peoples R China [7]Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Reprod Med, Shanghai 200025, Peoples R China
出处:
ISSN:

摘要:
The long-term maintenance of leukaemia stem cells (LSCs) is responsible for the high degree of malignancy in MLL (mixed-lineage leukaemia) rearranged acute myeloid leukaemia (AML). The DNA damage response (DDR) and DOT1L/H3K79me pathways are required to maintain LSCs in MLLr-AML, but little is known about their interplay. This study revealed that the DDR enzyme ATM regulates the maintenance of LSCs in MLLr-AML with a sequential protein-posttranslational-modification manner via CBP-DOT1L. We identified the phosphorylation of CBP by ATM, which confers the stability of CBP by preventing its proteasomal degradation, and characterised the acetylation of DOT1L by CBP, which mediates the high level of H3K79me2 for the expression of leukaemia genes in MLLr-AML. In addition, we revealed that the regulation of CBP-DOT1L axis in MLLr-AML by ATM was independent of DNA damage activation. Our findings provide insight into the signalling pathways involoved in MLLr-AML and broaden the understanding of the role of DDR enzymes beyond processing DNA damage, as well as identigying them as potent cancer targets.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 1 区 医学
小类 | 1 区 生化与分子生物学 1 区 遗传学 2 区 细胞生物学 2 区 肿瘤学
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 生化与分子生物学 1 区 遗传学 2 区 细胞生物学 2 区 肿瘤学
JCR分区:
出版当年[2022]版:
Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Q1 CELL BIOLOGY Q1 GENETICS & HEREDITY Q1 ONCOLOGY
最新[2023]版:
Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Q1 CELL BIOLOGY Q1 GENETICS & HEREDITY Q1 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者机构: [1]Tongji Univ, Tongji Hosp, Sch Med, Dept Hematol, Shanghai 200065, Peoples R China [2]Tongji Univ, East Hosp, Sch Med, Shanghai 200120, Peoples R China [3]Tongji Univ, Tongji Hosp, Sch Med, Postdoctoral Stn Clin Med, Shanghai 200092, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [6]Shanghai Jiao Tong Univ, Hongqiao Int Inst Med, Shanghai Tongren Hosp, Key Lab Cell Differentiat & Apoptosis,Chinese Mini, Shanghai 200025, Peoples R China [7]Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Reprod Med, Shanghai 200025, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:23568 今日访问量:2 总访问量:1284 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)